KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Thermo Fisher Scientific (TMO) Debt to Equity (2016 - 2025)

Historic Debt to Equity for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to $0.7.

  • Thermo Fisher Scientific's Debt to Equity fell 302.42% to $0.7 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.7, marking a year-over-year decrease of 302.42%. This contributed to the annual value of $0.63 for FY2024, which is 1557.69% down from last year.
  • Latest data reveals that Thermo Fisher Scientific reported Debt to Equity of $0.7 as of Q3 2025, which was down 302.42% from $0.7 recorded in Q2 2025.
  • In the past 5 years, Thermo Fisher Scientific's Debt to Equity ranged from a high of $0.85 in Q4 2021 and a low of $0.51 during Q3 2021
  • For the 5-year period, Thermo Fisher Scientific's Debt to Equity averaged around $0.71, with its median value being $0.72 (2024).
  • As far as peak fluctuations go, Thermo Fisher Scientific's Debt to Equity plummeted by 2858.25% in 2021, and later soared by 5244.29% in 2022.
  • Over the past 5 years, Thermo Fisher Scientific's Debt to Equity (Quarter) stood at $0.85 in 2021, then decreased by 8.23% to $0.78 in 2022, then decreased by 4.61% to $0.75 in 2023, then dropped by 15.58% to $0.63 in 2024, then rose by 10.87% to $0.7 in 2025.
  • Its Debt to Equity was $0.7 in Q3 2025, compared to $0.7 in Q2 2025 and $0.69 in Q1 2025.